Recommended daily treatment for chronic rhinosinusitis underused

August 25, 2016

Topical intranasal steroid therapy continues to be underused for patients with chronic rhinosinusitis (CRS) despite practice guidelines that recommend daily use, according to a study published online by JAMA Otolaryngology-Head & Neck Surgery.

Chronic rhinosinusitis (a condition in which the cavities around nasal passages [sinuses] become inflamed and swollen, which interferes with drainage and causes mucus buildup) is a common and expensive-to-treat disease, which is primarily managed with prolonged medical therapies. Topical intranasal steroid (INS) therapy has been shown to be highly effective at improving CRS-specific symptoms and quality of life. Deficiencies in utilization of intranasal steroid therapy may represent a gap in quality of care.

Luke Rudmik, M.D., M.Sc., of the University of Calgary, Canada, and colleagues evaluated the utilization patterns of topical intranasal steroid therapy for CRS in the Canadian population with a review of a Canadian population-based health care administrative database. A validated case definition for CRS was applied, and the utilization of topical intranasal steroid therapy within this cohort was quantified during the 2014-2015 fiscal year.

A total of 19,057 adult patients with CRS were evaluated. The overall rate of intranasal steroid spray utilization was 20 per 100 patients with CRS. In the 3,821 patients with CRS who used an intranasal steroid spray during 2014 to 2015, the average quantity of utilization was 2.4 U (1 U = 1 bottle per month) per patient. There was large geographic variation in both the rate and quantity of intranasal steroid spray utilization.

"Overall, the outcomes demonstrate that there is a significant under-use of INS spray for CRS patients; however, factors driving the underuse are currently unknown. Given that CRS practice guidelines provide strong recommendations for daily use of topical INS therapy, improving utilization of this treatment strategy may represent an opportunity to improve the quality of care," the authors write.
(JAMA Otolaryngol Head Neck Surg. Published online August 25, 2016. doi:10.1001/jamaoto.2016.1110. The study is available pre-embargo at the For The Media website.)

Editor's Note: This study was supported by an MSI Foundation grant and Petro-Canada Young Innovator in Community Health Sciences of Canada Award. All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported.

The JAMA Network Journals

Related Chronic Rhinosinusitis Articles from Brightsurf:

Chronic stress causes genetic changes in chickens
How can stress in animals be measured? Scientists from Uppsala University and elsewhere have now found that what are known as epigenetic biomarkers could be used to detect long-term exposure to stress in commercially raised chickens.

Predictors of chronic migraine
A review and meta-analysis found predictors of chronic migraine. Depression, high frequency attacks, medication overuse and allodynia increased the chances for new onset chronic migraine, while annual income -- US$ 50,000 showed a protective effect.

A vaccine against chronic inflammatory diseases
In animals, a vaccine modifying the composition and function of the gut microbiota provides protection against the onset of chronic inflammatory bowel diseases and certain metabolic disorders, such as diabetes and obesity.

Seeking better detection for chronic malaria
In people with chronic malaria, certain metabolic systems in the blood change to support a long-term host-parasite relationship, a finding that is key to eventually developing better detection, treatment and eradication of the disease, according to research published today in the Journal of Clinical Investigation Insight.

Is chronic rhinosinusitis associated with increased risk of depression, anxiety?
Chronic rhinosinusitis is a common condition marked by sinus inflammation that can make breathing difficult and cause face pain or tenderness.

Chronic kidney disease: Everyone's concern
850 million people worldwide are affected by kidney disease. This worrying figure was published last June.

Alcohol use in patients with chronic liver disease
A review article published in the New England Journal of Medicine discusses the effects of alcohol use on various forms of liver disease, as well as the assessment and treatment of alcohol use in patients with chronic liver disease.

New approach to treating chronic itch
Two receptors in the spinal cord and the right experimental drug: Researchers at the University of Zurich have discovered a new approach that suppresses itch.

Managing chronic pain with light
Scientists from EMBL Rome have identified the population of nerve cells in the skin that are responsible for sensitivity to gentle touch, and which cause severe pain in neuropathic pain patients.

A new solution for chronic pain
Neuropathic pain is a chronic illness affecting 7-10 percent of the population in France and for which there is no effective treatment.

Read More: Chronic Rhinosinusitis News and Chronic Rhinosinusitis Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to